https://ir.bioaffinitytech.com/ https://ir.bioaffinitytech.com/news-events https://ir.bioaffinitytech.com/news-events/press-releases https://ir.bioaffinitytech.com/news-events/ir-calendar https://ir.bioaffinitytech.com/news-events/email-alerts https://ir.bioaffinitytech.com/company-information https://ir.bioaffinitytech.com/company-information/management-team https://ir.bioaffinitytech.com/company-information/presentations https://ir.bioaffinitytech.com/company-information/contacts https://ir.bioaffinitytech.com/company-information/faq https://ir.bioaffinitytech.com/financial-information https://ir.bioaffinitytech.com/financial-information/financial-results https://ir.bioaffinitytech.com/financial-information/income-statement https://ir.bioaffinitytech.com/financial-information/balance-sheet https://ir.bioaffinitytech.com/financial-information/cash-flow https://ir.bioaffinitytech.com/stock-data/quote-chart https://ir.bioaffinitytech.com/stock-data/historical-data https://ir.bioaffinitytech.com/sec-filings https://ir.bioaffinitytech.com/sec-filings/all-sec-filings https://ir.bioaffinitytech.com/sec-filings/annual-reports https://ir.bioaffinitytech.com/sec-filings/quarterly-reports https://ir.bioaffinitytech.com/sec-filings/section-16-filings https://ir.bioaffinitytech.com/corporate-governance https://ir.bioaffinitytech.com/corporate-governance/board-of-directors https://ir.bioaffinitytech.com/corporate-governance/board-committees https://ir.bioaffinitytech.com/corporate-governance/governance-documents https://ir.bioaffinitytech.com/news-events/press-releases/detail/181/bioaffinity-technologies-reports-record-monthly-cypath-lung-unit-sales-and-significant-year-over-year-growth-in-april-2026 2026-05-12T09:15:00-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/180/bioaffinity-technologies-reports-first-quarter-2026-results-and-expanding-adoption-and-clinical-usage-of-cypath-lung 2026-05-08T08:30:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/179/bioaffinity-technologies-launches-new-study-to-expand-use-of-cypath-lung-technology-for-asthma-and-copd-diagnosis-and-treatment 2026-04-28T09:16:00-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/178/new-case-study-bioaffinity-technologies-cypath-lung-diagnostic-supports-physicians-assessment-prompts-follow-up-imaging-and-defers-unnecessary-biopsy 2026-04-14T08:00:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/177/bioaffinity-technologies-cypath-lung-to-be-featured-at-cleveland-clinic-annual-advances-in-early-lung-cancer-detection-symposium-april-16 2026-04-07T08:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/176/bioaffinity-technologies-cypath-lung-test-unit-sales-surged-146-year-over-year-in-q1-2026 2026-04-01T08:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/175/bioaffinity-technologies-to-host-live-virtual-physician-roundtable-on-integrating-cypath-lung-into-pulmonary-practice 2026-03-25T08:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/174/new-case-study-bioaffinity-technologies-cypath-lung-provides-actionable-results-and-helps-patient-avoid-costly-invasive-procedures 2026-03-17T07:45:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/173/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypath-lung 2026-03-13T08:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/172/bioaffinity-technologies-announces-initiation-of-large-scale-longitudinal-clinical-study-for-its-noninvasive-cypath-lung-cancer-diagnostic 2026-03-10T07:47:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/171/bioaffinity-technologies-presents-positive-research-findings-for-its-novel-diagnostic-platform-technology-to-identify-optimal-therapies-for-asthma-patients 2026-03-03T08:30:05-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/170/bioaffinity-technologies-announces-validation-study-with-brooke-army-medical-center-to-expand-sample-collection-options-for-the-cypath-lung-noninvasive-early-detection-lung-cancer-test 2026-02-25T08:30:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/169/new-case-study-highlights-ability-of-bioaffinity-technologies-cypath-lung-to-reduce-diagnostic-burden-for-patients-at-risk-for-lung-cancer 2026-02-19T11:00:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/168/clinical-utility-of-bioaffinity-technologies-cypath-lung-test-demonstrated-in-real-world-case-study 2026-02-17T08:00:04-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/167/bioaffinity-technologies-appoints-nationally-recognized-pulmonary-and-lung-cancer-authorities-to-its-medical-and-scientific-advisory-board 2026-02-09T08:00:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/166/bioaffinity-technologies-laboratory-maintains-prestigious-college-of-american-pathologists-cap-accreditation 2026-01-07T08:00:03-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/165/bioaffinity-technologies-noninvasive-cypath-lung-test-to-be-highlighted-at-american-cancer-society-national-lung-cancer-roundtable 2025-12-03T08:00:06-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/164/bioaffinity-technologies-reports-third-quarter-2025-financial-results 2025-11-14T08:00:03-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/163/bioaffinity-technologies-reports-accelerating-month-over-month-growth-in-cypath-lung-test-volume 2025-11-05T08:00:03-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/162/bioaffinity-technologies-announces-acceptance-of-australian-patent-application-for-platform-to-detect-and-characterize-multiple-lung-diseases 2025-10-28T08:00:13-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/161/bioaffinity-technologies-presents-research-supporting-cypath-lung-processing-methods-at-chest-2025 2025-10-20T08:00:09-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/160/bioaffinity-technologies-announces-notification-of-allowance-for-u-s-patent-application-for-its-diagnostic-algorithm-and-test-method-for-lung-cancer 2025-10-16T08:00:15-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/159/bioaffinity-technologies-regains-compliance-with-nasdaq-listing-requirements 2025-10-15T08:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/158/bioaffinity-technologies-inc-announces-closing-of-1-8-million-registered-direct-financing-of-common-stock-priced-at-the-market-under-nasdaq-rules 2025-10-09T13:00:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/157/bioaffinity-technologies-inc-announces-approximately-1-8-million-registered-direct-financing-of-common-stock-priced-at-the-market-under-nasdaq-rules 2025-10-08T15:45:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/156/bioaffinity-technologies-reports-record-growth-in-cypath-lung-test-volume-for-third-quarter-2025 2025-10-07T08:00:06-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/155/bioaffinity-technologies-announces-closing-of-4-8-million-public-offering 2025-09-30T12:15:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/154/bioaffinity-technologies-announces-pricing-of-4-8-million-public-offering 2025-09-29T15:51:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/153/bioaffinity-technologies-adds-to-growing-number-of-case-studies-demonstrating-clinical-value-of-cypath-lung 2025-09-26T08:00:05-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/152/bioaffinity-technologies-announces-1-for-30-reverse-stock-split-effective-at-the-open-of-trading-on-september-19-2025 2025-09-17T08:15:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/151/case-study-cypath-lung-identifies-lung-cancer-in-patient-with-difficult-to-diagnose-ground-glass-pulmonary-nodules 2025-09-09T08:00:08-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/150/u-s-medicine-magazine-spotlights-cypath-lung-as-promising-tool-to-improve-lung-cancer-detection-in-veterans-lower-costs-to-the-va 2025-09-03T08:00:20-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/149/bioaffinity-technologies-appoints-new-members-to-board-of-directors 2025-08-18T08:00:08-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/148/bioaffinity-technologies-announces-closing-of-private-placement-and-warrant-inducement-transaction-for-approximately-1-2-million-in-gross-proceeds 2025-08-14T16:31:16-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/147/bioaffinity-technologies-reports-second-quarter-2025-results 2025-08-14T08:00:12-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/146/bioaffinity-technologies-announces-pricing-of-private-placement-and-warrant-inducement-transaction-for-approximately-1-2-million-in-gross-proceeds 2025-08-13T09:25:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/145/bioaffinity-technologies-reports-accelerating-growth-in-cypath-lung-test-sales 2025-08-13T08:00:06-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/144/case-study-cypath-lung-detects-stage-1a-lung-cancer-in-high-risk-patient-with-inconclusive-imaging-and-low-risk-serum-test-results 2025-07-29T08:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/143/case-study-cypath-lung-detects-neuroendocrine-tumor-missed-by-other-diagnostic-tools 2025-07-23T08:00:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/142/canada-awards-new-patent-to-bioaffinity-technologies-for-cypath-lung-companys-noninvasive-lung-cancer-diagnostic 2025-07-22T09:00:09-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/141/bioaffinity-technologies-announces-notification-of-china-patent-award-for-companys-noninvasive-lung-cancer-diagnostic 2025-07-15T09:00:05-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/140/case-study-cypath-lung-detects-stage-1a-lung-cancer-in-high-risk-patient-with-inconclusive-imaging 2025-07-09T09:00:07-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/139/bioaffinity-technologies-scientists-present-breakthrough-cancer-research-at-rna-therapeutics-conference 2025-06-26T09:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/138/bioaffinity-technologies-expands-patent-portfolio-with-china-grant-for-sirna-based-cancer-therapy 2025-06-24T09:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/137/bioaffinity-technologies-president-and-ceo-maria-zannes-appointed-to-american-lung-association-in-texas-leadership-board 2025-06-11T09:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/136/bioaffinity-technologies-works-with-cardinal-health-optifreight-logistics-to-help-meet-demand-for-cypath-lung 2025-06-03T09:00:04-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/135/bioaffinity-technologies-announces-new-u-s-patent-for-novel-broad-spectrum-cancer-therapeutics 2025-05-28T09:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/134/bioaffinity-technologies-appoints-dr-gordon-downie-md-phd-as-chief-medical-officer 2025-05-20T09:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/133/bioaffinity-technologies-reports-first-quarter-2025-results 2025-05-15T08:30:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/132/independent-white-paper-highlights-real-world-impact-of-bioaffinity-technologies-cypath-lung-in-diagnosing-early-stage-lung-cancer 2025-05-08T09:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/131/bioaffinity-technologies-announces-closing-of-3-25-million-offering 2025-05-07T13:00:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/130/bioaffinity-technologies-announces-pricing-of-3-25-million-offering 2025-05-06T09:25:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/129/bioaffinity-technologies-increases-efficiency-of-cypath-lung-test-by-boosting-data-acquisition-throughput-by-50-and-reducing-unit-cost 2025-04-17T09:15:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/128/bioaffinity-technologies-reports-record-9-4-million-revenue-for-2024 2025-03-31T09:28:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/127/case-study-bioaffinity-technologies-cypath-lung-detects-second-primary-lung-cancer-in-patient-with-history-of-lung-cancer 2025-03-26T09:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/126/case-study-bioaffinity-technologies-positive-cypath-lung-result-leads-to-detecting-breast-cancer-recurrence 2025-03-19T09:00:07-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/125/physicians-case-studies-offer-insight-into-use-and-benefit-of-cypath-lung-in-avoiding-unnecessary-invasive-procedures-and-detecting-lung-cancer 2025-03-13T09:00:09-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/124/bioaffinity-technologies-announces-targeted-actions-to-cut-4-million-in-costs-and-drive-cypath-lung-sales-growth 2025-03-06T08:00:11-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/123/bioaffinity-technologies-announces-closing-of-warrant-inducement-transaction-for-aggregate-gross-proceeds-of-1-4-million 2025-02-26T11:30:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/122/bioaffinity-technologies-announces-warrant-inducement-for-aggregate-gross-proceeds-of-1-4-million 2025-02-25T09:58:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/121/bioaffinity-technologies-announces-acceptance-of-patent-application-for-early-stage-lung-cancer-diagnostic 2025-01-22T08:00:14-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/120/bioaffinity-technologies-reports-positive-results-from-texas-beta-launch-of-cypath-lung 2025-01-13T08:00:26-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/119/join-bioaffinity-technologies-exclusive-live-investor-webinar-and-qa-session-on-thursday-december-19 2024-12-17T08:00:07-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/118/bioaffinity-technologies-set-for-continued-expansion-in-2025 2024-12-12T08:00:10-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/117/veterans-research-foundation-spotlights-cypath-lungs-addition-to-the-federal-supply-schedule 2024-12-05T08:00:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/116/bioaffinity-technologies-reports-2-4-million-revenue-for-q3-2024 2024-11-14T08:00:07-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/115/bioaffinity-technologies-appoints-new-chief-science-officer-to-spearhead-product-development 2024-11-04T08:00:03-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/114/bioaffinity-technologies-announces-award-of-japanese-patent-for-cypath-lung 2024-10-30T08:00:07-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/113/bioaffinity-technologies-announces-closing-of-2-6-million-registered-direct-offering-concurrent-private-placement 2024-10-21T10:45:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/112/bioaffinity-technologies-announces-pricing-of-2-66-million-registered-direct-offering-concurrent-private-placement 2024-10-18T12:45:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/111/bioaffinitys-cypath-lung-cancer-test-supported-by-newly-published-flow-cytometry-guidelines 2024-10-16T08:00:10-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/110/bioaffinity-technologies-names-j-michael-edwards-as-chief-financial-officer 2024-10-10T08:00:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/109/bioaffinity-technologies-awarded-u-s-federal-supply-schedule-contract-for-cypath-lung-test 2024-10-09T08:00:34-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/108/peer-reviewed-study-bioaffinity-technologies-cypath-lung-test-shows-potential-significant-healthcare-savings-by-reducing-unnecessary-follow-up-medical-complications-and-overdiagnosis 2024-09-18T08:00:05-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/107/bioaffinity-technologies-cfo-to-depart-for-new-opportunity-j-michael-edwards-to-return-as-interim-cfo 2024-08-23T17:15:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/106/bioaffinity-technologies-reports-2-4-million-revenue-for-q2-driven-by-growing-cypath-lung-sales 2024-08-14T09:25:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/105/bioaffinity-technologies-announces-closing-of-registered-direct-offering-concurrent-private-placement-and-warrant-inducement-for-aggregate-gross-proceeds-of-1-75-million 2024-08-05T13:17:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/104/bioaffinity-technologies-announces-pricing-of-registered-direct-offering-and-concurrent-private-placement-and-warrant-inducement-for-aggregate-gross-proceeds-of-1-75-million 2024-08-02T09:25:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/103/bioaffinity-technologies-reports-217-sales-growth-in-second-quarter-2024-for-cypath-lung 2024-07-09T08:00:09-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/102/bioaffinity-technologies-reports-accelerating-growth-of-physician-practices-ordering-cypath-lung-tests 2024-06-12T08:00:10-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/101/bioaffinity-technologies-reports-record-q1-revenue-driven-by-accelerating-growth-of-cypath-lung-sales-and-increased-laboratory-volumes 2024-05-15T09:15:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/100/bioaffinity-technologies-news-update 2024-05-02T08:00:08-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/99/bioaffinity-technologies-advances-new-product-development-initiatives-to-accelerate-next-phase-of-growth 2024-04-24T08:00:06-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/98/bioaffinity-technologies-expands-campaign-to-support-american-cancer-society-initiative-for-lung-cancer-screening 2024-04-09T08:00:10-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/97/bioaffinity-technologies-reports-fourth-quarter-and-full-year-2023-financial-results 2024-04-01T11:08:05-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/96/bioaffinity-technologies-announces-closing-of-2-5-million-registered-direct-offering-and-concurrent-private-placement 2024-03-08T12:45:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/95/bioaffinity-technologies-announces-pricing-of-2-5-million-registered-direct-offering-and-concurrent-private-placement 2024-03-06T09:46:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/94/bioaffinity-technologies-reports-accelerating-sales-growth-of-cypath-lung 2024-03-05T08:00:05-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/93/bioaffinity-technologies-news-update 2024-02-21T08:00:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/92/medical-director-of-lung-innovations-network-and-the-lung-center-at-penn-highlands-healthcare-sandeep-bansal-m-d-joins-bioaffinity-technologies-medical-and-scientific-advisory-board-and-incorporates-cypath-lung-into-medical-practice 2024-02-06T08:00:10-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/91/bioaffinity-technologies-in-the-news 2024-01-30T08:00:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/90/bioaffinity-technologies-announces-award-of-therapeutic-patent-for-treatment-of-cancer 2024-01-23T08:00:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/89/bioaffinity-technologies-in-the-news 2024-01-08T08:00:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/88/bioaffinity-technologies-appoints-jamie-platt-ph-d-to-its-board-of-directors 2023-12-05T08:00:07-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/87/cms-posts-final-payment-determination-for-bioaffinity-technologies-cypath-lung-effective-january-2024 2023-11-30T08:00:07-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/86/bioaffinity-technologies-vp-david-elzi-ph-d-named-to-american-society-for-cell-biology-post 2023-11-28T08:00:04-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/85/bioaffinity-technologies-teams-with-american-cancer-society-to-raise-funds-for-lung-cancer-screening 2023-11-15T08:00:03-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/84/bioaffinity-technologies-reports-third-quarter-2023-financial-results-and-provides-business-update 2023-11-14T16:01:06-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/83/bioaffinity-technologies-names-dallas-j-coleman-as-national-director-of-sales 2023-11-06T08:00:04-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/82/bioaffinity-technologies-to-present-at-the-8th-annual-dawson-james-small-cap-growth-conference 2023-10-10T08:00:04-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/81/bioaffinity-technologies-acquires-laboratory-assets-of-precision-pathology-services 2023-09-19T08:00:10-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/80/bioaffinity-technologies-to-participate-in-the-h-c-wainwright-global-investment-conference 2023-09-07T08:00:06-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/79/bioaffinity-technologies-reports-second-quarter-2023-financial-results-and-provides-business-update 2023-08-14T17:03:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/78/ama-issues-cpt-code-for-bioaffinity-technologies-cypath-lung-test-for-early-stage-lung-cancer 2023-07-12T08:00:07-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/77/bioaffinity-technologies-presents-research-findings-at-umass-rna-therapeutics-symposium 2023-06-15T08:00:04-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/76/bioaffinity-technologies-presents-research-findings-at-cyto-2023 2023-05-22T08:00:05-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/75/bioaffinity-technologies-reports-first-quarter-2023-financial-results 2023-05-15T08:00:07-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/74/bioaffinity-technologies-names-michael-dougherty-as-chief-financial-officer 2023-05-15T12:24:30-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/73/bioaffinity-technologies-presents-at-cleveland-clinic-lung-cancer-symposium 2023-04-25T08:00:04-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/72/bioaffinity-technologies-to-ring-nasdaq-closing-bell-today 2023-04-05T08:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/71/bioaffinity-technologies-reports-fourth-quarter-and-full-year-2022-financial-results 2023-03-31T17:52:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/70/bioaffinity-technologies-announces-publication-of-peer-reviewed-paper-on-proprietary-beads-used-in-cypath-lung-for-noninvasive-detection-of-early-stage-lung-cancer 2023-03-28T08:00:03-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/69/bioaffinity-technologies-to-report-fourth-quarter-2022-financial-results-on-march-31-2023 2023-03-24T08:00:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/68/bioaffinity-technologies-appoints-julie-anne-overton-director-of-corporate-communications 2023-02-13T08:00:07-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/67/bioaffinity-technologies-announces-publication-of-results-of-clinical-trial-in-peer-reviewed-journal-respiratory-research 2023-01-24T08:00:05-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/66/bioaffinity-technologies-announces-notice-to-award-u-s-patent-protecting-novel-compounds-for-specific-delivery-of-cancer-treatments 2023-01-04T08:00:09-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/65/bioaffinity-technologies-expands-diagnostic-division-with-promotions-and-new-hires-to-strengthen-clinical-bench 2022-12-15T08:30:04-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/64/bioaffinity-technologies-presents-proprietary-cancer-therapeutic-research-at-joint-ascb-embo-meeting 2022-12-01T08:00:04-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/63/bioaffinity-technologies-reports-third-quarter-2022-financial-results-and-provides-business-update 2022-11-14T07:30:02-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/62/bioaffinity-technologies-announces-sheila-habib-md-and-david-hill-md-join-the-companys-scientific-and-medical-advisory-board 2022-11-10T08:15:01-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/61/bioaffinity-technologies-to-report-third-quarter-2022-financial-results 2022-11-08T08:00:09-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/60/bioaffinity-technologies-announces-award-of-therapeutic-patents-in-china-mexico-and-australia 2022-10-25T09:15:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/59/bioaffinity-technologies-presents-results-from-flow-cytometry-analysis-of-the-lung-at-chest-conference 2022-10-12T08:15:02-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/58/bioaffinity-technologies-receives-additional-7-7m-from-exercise-of-warrants-total-capital-from-public-offering-increases-to-approximately-15-6m 2022-09-28T08:15:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/57/bioaffinity-technologies-publishes-peer-reviewed-results-of-high-throughput-flow-cytometry-use-for-evaluating-lung-health-in-plos-one 2022-09-14T08:15:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/56/bioaffinity-technologies-inc-announces-closing-of-7-8-million-initial-public-offering 2022-09-06T11:28:01-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/55/bioaffinity-technologies-announces-pricing-of-ipo 2022-09-01T08:15:00-04:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/5/bioaffinity-technologies-presents-its-cancer-therapeutic-research-at-joint-ascb-embo-meeting 2022-01-12T17:07:38-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/6/bioaffinity-technologies-announces-xavier-t-reveles-promoted-to-vice-president-of-operations 2022-01-12T17:07:38-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/7/bioaffinity-technologies-announces-award-of-therapeutic-patent-for-treatment-of-cancer 2022-01-12T17:07:38-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/8/bioaffinity-technologies-announces-precision-pathology-services-validation-of-novel-non-invasive-early-lung-cancer-test 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/9/bioaffinity-technologies-publishes-sputum-processing-and-innovative-high-throughput-analysis-methods 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/10/bioaffinity-technologies-presents-scientific-discoveries-advancing-cancer-therapeutics-and-diagnostics-at-two-global-conferences 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/11/leading-cell-biology-journal-publishes-bioaffinity-technologies-groundbreaking-research-on-porphyrins 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/12/bioaffinity-technologies-executes-agreement-with-fosun-long-march-to-evaluate-cypath-lung-for-commercialization-in-china 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/13/bioaffinity-technologies-to-present-at-2020-american-society-of-cell-biology-meeting 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/14/bioaffinity-technologies-to-present-poster-at-world-conference-on-lung-cancer-2020 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/15/smiths-medical-and-bioaffinity-technologies-partner-to-advance-non-invasive-testing-for-early-lung-cancer 2022-01-12T17:07:39-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/16/bioaffinity-technologies-announces-dr-martin-tammemgi-to-chair-scientific-and-medical-advisory-board 2022-01-12T17:07:40-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/17/precision-pathology-services-and-bioaffinity-technologies-announce-initiation-of-clia-validation-for-non-invasive-early-lung-cancer-test 2022-01-12T17:07:40-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/18/bioaffinity-technologies-announces-poster-presentation-at-cyto-2020-conference 2022-01-12T17:07:40-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/19/bioaffinity-technologies-announces-closing-of-5000000-convertible-note-financing 2022-01-12T17:07:40-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/20/stephen-squinto-ph-d-named-vice-chairman-of-bioaffinity-technologies 2022-01-12T17:07:40-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/21/bioaffinity-cancer-research-laboratories-named-for-philanthropist-harvey-sandler 2022-01-12T17:07:40-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/22/bioaffinity-technologies-validation-trial-for-non-invasive-lung-cancer-test-results-in-high-sensitivity-and-specificity 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/23/company-profile-for-bioaffinity-technologies-inc 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/24/bioaffinity-technologies-joins-national-lung-cancer-roundtable 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/25/bioaffinity-technologies-announces-members-of-its-scientific-and-medical-advisory-board 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/26/bioaffinity-technologies-announces-formation-of-scientific-and-medical-advisory-board-m-patricia-rivera-md-joins-board-as-chair 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/27/bioaffinity-technologies-selected-as-finalist-for-cancer-innovation-award 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/28/bioaffinity-technologies-announces-award-of-canadian-patent 2022-01-12T17:07:41-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/29/south-texas-veterans-health-care-system-joins-test-validation-trial-of-bioaffinitys-cypath-lung 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/30/bioaffinity-licenses-cypath-lung-to-precision-pathology-services 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/31/mount-sinai-joins-test-validation-trial-of-bioaffinitys-cypath-lung 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/32/bioaffinity-technologies-welcomes-mohsin-y-meghji-to-board-of-directors 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/33/bioaffinity-technologies-opens-test-validation-trial-of-cypath-lung 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/34/bioaffinity-technologies-welcomes-peter-s-knight-to-board-of-directors 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/35/bioaffinity-technologies-joins-early-detection-research-network 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/36/bioaffinity-technologies-to-present-at-biotech-showcase-annual-conference 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/37/bioaffinity-technologies-welcomes-new-board-members 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/38/bioaffinity-technologies-announces-4-million-series-a-funding 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/39/bioaffinity-technologies-adds-four-scientists-to-research-commercialization-team 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/40/bioaffinity-technologies-announces-award-of-european-union-patent 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/41/city-of-san-antonio-invests-in-bioaffinity-technologies 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/42/bioaffinity-technologies-announces-award-of-hong-kong-patent 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/43/bioaffinity-awarded-new-patent-companys-patent-portfolio-continues-to-expand 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/44/bioaffinity-technologies-and-ut-health-science-center-collaborate-to-optimize-cancer-diagnostics-and-therapeutics 2022-01-12T17:07:42-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/45/bioaffinity-technologies-appoints-new-senior-vp-for-research-development-of-therapeutics 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/46/bioaffinity-technologies-forms-subsidiary-to-focus-on-targeted-cancer-drug-delivery 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/47/bioaffinity-technologies-presents-cypath-technology-at-international-lung-cancer-conference 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/48/bioaffinity-technologies-appoints-new-science-team 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/49/bioaffinity-technologies-announces-patent-award-in-china 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/50/bioaffinity-technologies-announces-novel-cancer-bio-label-presented-at-ascb-annual-meeting 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/51/bioaffinity-technologies-presents-at-mcdermott-pharmaceuticalmedtech-dealmaking-symposium 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/52/bioaffinity-technologies-welcomes-new-board-members 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/53/bioaffinity-technologies-ut-health-science-center-san-antonio-announce-collaboration-to-advance-non-invasive-cancer-diagnostic 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/news-events/press-releases/detail/54/clinical-study-for-non-invasive-lung-cancer-test-reports-promising-results-in-journal-of-thoracic-oncology 2022-01-12T17:07:43-05:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-024619/forms-8.htm 2026-05-20T16:26:43-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-023063/form424b3.htm 2026-05-14T16:09:14-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/9999999995-26-001591/primary_doc.html 2026-05-13T06:06:30-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-022428/form8-k.htm 2026-05-12T09:20:52-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-022044/form10-q.htm 2026-05-11T07:13:10-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-021861/form8-k.htm 2026-05-08T08:31:25-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-020725/forms-1.htm 2026-04-30T17:08:25-04:00 https://ir.bioaffinitytech.com/sec-filings/all-sec-filings/content/0001493152-26-020591/form8-k.htm 2026-04-30T16:34:49-04:00 https://ir.bioaffinitytech.com/privacy-policy https://ir.bioaffinitytech.com/disclaimer https://ir.bioaffinitytech.com/sitemap